Literature DB >> 16987682

Medical management of patients over 50 years admitted to orthopedic surgery for low-energy fracture.

Régis Levasseur1, Jean-Pierre Sabatier, Catherine Guilcher, Geneviève Guaydier-Souquières, Valérie Costentin-Pignol, Pierre-Yves Jean-Jacques, Christophe Hulet, Claude Vielpeau, Christian Marcelli.   

Abstract

OBJECTIVE: To develop a cost-effective strategy for improving osteoporosis management in patients admitted to an orthopedic surgery department for low-energy fractures.
METHODS: From November 2003 to July 2004, all patients over 50 years admitted to the orthopedics department of the Caen Teaching Hospital (France) for low-energy fractures were identified and evaluated by rheumatology department physicians in the same hospital.
RESULTS: During the study period, 313 patients were identified, 257 women (mean age, 79.5+/-10.2 years) and 56 men (mean age, 74.6+/-10.8 years), each with one fracture (proximal femur, 58.9%; wrist, 13%). Among them, 91 (29%) had a previous history of osteoporotic fractures. Mean bone mineral density (BMD) values were lower at the femoral neck than at the total hip or lumbar spine (e.g. in women, -2.3+/-0.9 versus -1.8+/-1.0 and -1.4+/-1.7, respectively). Osteoporosis treatment was given to 88 (28%) patients and consisted of calcium and vitamin D supplements, combined with alendronate in 32 patients. Complete loss of self-sufficiency occurred in 73 patients. Thus, 161 patients (88 with osteoporosis treatment and 73 with loss of self-sufficiency) received optimal treatment.
CONCLUSION: Cooperation between the orthopedics and rheumatology departments improved the management of osteoporosis in patients with low-energy fractures. However, appropriate investigation and treatment of osteoporosis proved difficult in the oldest old and in patients with cognitive impairments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987682     DOI: 10.1016/j.jbspin.2006.03.003

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  8 in total

Review 1.  Bone mineral density testing after fragility fracture: Informative test results likely.

Authors:  Joshua Posen; Dorcas E Beaton; Joanna Sale; Earl R Bogoch
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

Review 2.  Coordinator-based systems for secondary prevention in fragility fracture patients.

Authors:  D Marsh; K Akesson; D E Beaton; E R Bogoch; S Boonen; M-L Brandi; A R McLellan; P J Mitchell; J E M Sale; D A Wahl
Journal:  Osteoporos Int       Date:  2011-05-24       Impact factor: 4.507

Review 3.  Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients.

Authors:  J E M Sale; D Beaton; J Posen; V Elliot-Gibson; E Bogoch
Journal:  Osteoporos Int       Date:  2011-05-24       Impact factor: 4.507

4.  Mortality rates after incident non-traumatic fractures in older men and women.

Authors:  S Morin; L M Lix; M Azimaee; C Metge; P Caetano; W D Leslie
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

Review 5.  A review of patient-centred post-fracture interventions in the context of theories of health behaviour change.

Authors:  R Sujic; M A Gignac; R Cockerill; D E Beaton
Journal:  Osteoporos Int       Date:  2011-01-11       Impact factor: 4.507

6.  Ankle fracture configuration following treatment with and without arthroscopic-assisted reduction and fixation.

Authors:  Chayanin Angthong
Journal:  World J Orthop       Date:  2016-04-18

7.  Factors influencing the treatment of osteoporosis following fragility fracture.

Authors:  L Bessette; S Jean; K S Davison; S Roy; L-G Ste-Marie; J P Brown
Journal:  Osteoporos Int       Date:  2009-03-31       Impact factor: 4.507

8.  Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility.

Authors:  Gilles Loggia; Elpidio Attoh-Mensah; Kristell Pothier; Rémy Morello; Pascale Lescure; Marie-Laure Bocca; Christian Marcelli; Chantal Chavoix
Journal:  Front Pharmacol       Date:  2020-01-30       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.